• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立 II/III 级星形细胞瘤的磁共振成像和临床特征模型,以预测 IDH 突变状态。

Modelling MR and clinical features in grade II/III astrocytomas to predict IDH mutation status.

机构信息

Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, London, UK; Imaging Department, UCLH NHS Trust, London, UK.

National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.

出版信息

Eur J Radiol. 2019 May;114:120-127. doi: 10.1016/j.ejrad.2019.03.003. Epub 2019 Mar 14.

DOI:10.1016/j.ejrad.2019.03.003
PMID:31005161
Abstract

BACKGROUND AND PURPOSE

There is increasing evidence that many IDH wildtype (IDHwt) astrocytomas have a poor prognosis and although MR features have been identified, there remains diagnostic uncertainty in the clinic. We have therefore conducted a comprehensive analysis of conventional MR features of IDHwt astrocytomas and performed a Bayesian logistic regression model to identify critical radiological and basic clinical features that can predict IDH mutation status.

MATERIALS AND METHODS

146 patients comprising 52 IDHwt astrocytomas (19 WHO Grade II diffuse astrocytomas (A II) and 33 WHO Grade III anaplastic astrocytomas (A III)), 68 IDHmut astrocytomas (53 A II and 15 A III) and 26 GBM were studied. Age, sex, presenting symptoms and Overall Survival were recorded. Two neuroradiologists assessed 23 VASARI imaging descriptors of MRI features and the relation between IDH mutation status and MR and basic clinical features was modelled by Bayesian logistic regression, and survival by Kaplan-Meier plots.

RESULTS

The features of greatest predictive power for IDH mutation status were, age at presentation (OR = 0.94 +/-0.03), tumour location within the thalamus (OR = 0.15 +/-0.25), involvement of speech receptive areas (OR = 0.21 +/-0.26), deep white matter invasion of the brainstem (OR = 0.10 +/-0.32), and T1/FLAIR signal ratio (OR = 1.63 +/-0.64). A logistic regression model based on these five features demonstrated excellent out-of-sample predictive performance (AUC = 0.92 +/-0.07; balanced accuracy 0.81 +/-0.09). Stepwise addition of further VASARI variables did not improve performance.

CONCLUSION

Five demographic and VASARI features enable excellent individual prediction ofIDH mutation status, opening the way to identifying patients with IDHwt astrocytomas for earlier tissue diagnosis and more aggressive management.

摘要

背景与目的

越来越多的证据表明,许多 IDH 野生型(IDHwt)星形细胞瘤预后较差,尽管已经确定了 MRI 特征,但临床上仍存在诊断不确定性。因此,我们对 IDHwt 星形细胞瘤的常规 MRI 特征进行了全面分析,并进行了贝叶斯逻辑回归模型分析,以确定能够预测 IDH 突变状态的关键影像学和基本临床特征。

材料与方法

共纳入 146 例患者,其中 52 例 IDHwt 星形细胞瘤(19 例 WHO 分级 II 级弥漫性星形细胞瘤(A II)和 33 例 WHO 分级 III 级间变性星形细胞瘤(A III)),68 例 IDHmut 星形细胞瘤(53 例 A II 和 15 例 A III)和 26 例 GBM。记录年龄、性别、首发症状和总生存期。两名神经放射科医生评估了 23 个 VASARI 成像描述符的 MRI 特征,采用贝叶斯逻辑回归模型对 IDH 突变状态与 MR 和基本临床特征之间的关系进行建模,并通过 Kaplan-Meier 图进行生存分析。

结果

对 IDH 突变状态具有最大预测能力的特征是发病时的年龄(OR=0.94±0.03)、丘脑内肿瘤位置(OR=0.15±0.25)、语言接受区受累(OR=0.21±0.26)、脑干深部白质侵犯(OR=0.10±0.32)和 T1/FLAIR 信号比(OR=1.63±0.64)。基于这五个特征的逻辑回归模型显示出出色的样本外预测性能(AUC=0.92±0.07;平衡准确性 0.81±0.09)。逐步增加其他 VASARI 变量并不能提高性能。

结论

五个人口统计学和 VASARI 特征能够极好地预测 IDH 突变状态,为识别 IDHwt 星形细胞瘤患者以进行早期组织诊断和更积极的治疗开辟了道路。

相似文献

1
Modelling MR and clinical features in grade II/III astrocytomas to predict IDH mutation status.建立 II/III 级星形细胞瘤的磁共振成像和临床特征模型,以预测 IDH 突变状态。
Eur J Radiol. 2019 May;114:120-127. doi: 10.1016/j.ejrad.2019.03.003. Epub 2019 Mar 14.
2
Noninvasive Assessment of Mutational Status in World Health Organization Grade II and III Astrocytomas Using DWI and DSC-PWI Combined with Conventional MR Imaging.使用扩散加权成像(DWI)和动态磁敏感对比增强灌注加权成像(DSC-PWI)联合传统磁共振成像对世界卫生组织二级和三级星形细胞瘤突变状态进行无创评估
AJNR Am J Neuroradiol. 2017 Jun;38(6):1138-1144. doi: 10.3174/ajnr.A5171. Epub 2017 Apr 27.
3
Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.高级影像学参数可提高弥漫性低级别胶质瘤 IDH 突变型无 1p19q 联合缺失亚型的预测准确性:T2/FLAIR 不匹配征象的附加价值。
Eur Radiol. 2020 Feb;30(2):844-854. doi: 10.1007/s00330-019-06395-2. Epub 2019 Aug 24.
4
Anatomical and subcortical invasiveness in diffuse low-grade astrocytomas differ between IDH status and provide prognostic information.弥漫性低级别星形细胞瘤的 IDH 状态与解剖和皮质下侵袭性不同,并提供预后信息。
Ups J Med Sci. 2024 Sep 3;129. doi: 10.48101/ujms.v129.10799. eCollection 2024.
5
Magnetic resonance imaging criteria for prediction of isocitrate dehydrogenase (IDH) mutation status in patients with grade II-III astrocytoma and oligodendroglioma.磁共振成像标准预测 II-III 级星形细胞瘤和少突胶质细胞瘤患者异柠檬酸脱氢酶(IDH)突变状态。
Clin Neurol Neurosurg. 2021 Aug;207:106745. doi: 10.1016/j.clineuro.2021.106745. Epub 2021 Jun 8.
6
The reliability and interobserver reproducibility of T2/FLAIR mismatch in the diagnosis of IDH-mutant astrocytomas.T2/FLAIR 不匹配对 IDH 突变型星形细胞瘤诊断的可靠性和观察者间可重复性。
Diagn Interv Radiol. 2021 Nov;27(6):796-801. doi: 10.5152/dir.2021.20624.
7
The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study.T2-FLAIR 不匹配征象在 II 级和 III 级胶质瘤中的临床意义:一项基于人群的研究。
BMC Cancer. 2020 May 20;20(1):450. doi: 10.1186/s12885-020-06951-w.
8
MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis.磁共振成像特征和 IDH 基因突变状态在二级弥漫性胶质瘤中的作用:对诊断和预后的影响。
AJR Am J Roentgenol. 2018 Mar;210(3):621-628. doi: 10.2214/AJR.17.18457. Epub 2017 Dec 20.
9
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO.异柠檬酸脱氢酶(IDH)突变型弥漫性和间变性星形细胞瘤在发病年龄上相似,生存差异不大:这是世界卫生组织面临的分级难题。
Acta Neuropathol. 2015 Jun;129(6):867-73. doi: 10.1007/s00401-015-1438-8. Epub 2015 May 12.
10
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities.成人 IDH 野生型星形细胞瘤在生物学和临床上可转化为其他肿瘤实体。
Acta Neuropathol. 2015 Sep;130(3):407-17. doi: 10.1007/s00401-015-1454-8. Epub 2015 Jun 19.

引用本文的文献

1
Establishment and validation of a nomogram for predicting IDH-wildtype glioblastomas in nonenhancing adult-type diffuse gliomas.预测非强化型成人型弥漫性胶质瘤中异柠檬酸脱氢酶野生型胶质母细胞瘤的列线图的建立与验证
Neurooncol Adv. 2025 Feb 8;7(1):vdaf035. doi: 10.1093/noajnl/vdaf035. eCollection 2025 Jan-Dec.
2
Structured reporting of gliomas based on VASARI criteria to improve report content and consistency.基于VASARI标准对胶质瘤进行结构化报告,以提高报告内容和一致性。
BMC Med Imaging. 2025 Mar 24;25(1):99. doi: 10.1186/s12880-025-01603-6.
3
Qualitative MRI features in the differentiation between primary and secondary CNS lymphoma.
原发性与继发性中枢神经系统淋巴瘤鉴别中的磁共振成像定性特征
Neuroradiology. 2025 Mar 17. doi: 10.1007/s00234-025-03594-1.
4
Prediction of isocitrate dehydrogenase mutation status in WHO grade II glioma by diffusion kurtosis imaging.基于扩散峰度成像预测世界卫生组织二级胶质瘤中的异柠檬酸脱氢酶突变状态
Pol J Radiol. 2024 Dec 20;89:e566-e572. doi: 10.5114/pjr/195521. eCollection 2024.
5
Recursive partitioning analysis for survival stratification and early imaging prediction of molecular biomarker in glioma patients.递归分区分析在胶质瘤患者的生存分层和分子生物标志物早期影像学预测中的应用。
BMC Cancer. 2024 Jul 9;24(1):818. doi: 10.1186/s12885-024-12542-w.
6
Ten Years of VASARI Glioma Features: Systematic Review and Meta-Analysis of Their Impact and Performance.VASARI 胶质瘤特征十年:系统评价和荟萃分析及其影响和性能。
AJNR Am J Neuroradiol. 2024 Aug 9;45(8):1053-1062. doi: 10.3174/ajnr.A8274.
7
Clinical and imaging characteristics of supratentorial glioma with IDH2 mutation.伴有 IDH2 突变的幕上脑胶质瘤的临床和影像学特征。
Neuroradiology. 2024 Jun;66(6):973-981. doi: 10.1007/s00234-024-03361-8. Epub 2024 Apr 24.
8
Nomogram incorporating preoperative MRI-VASARI features for differentiating intracranial extraventricular ependymoma from glioblastoma.纳入术前MRI-VASARI特征的列线图,用于鉴别颅内脑室外室管膜瘤与胶质母细胞瘤。
Quant Imaging Med Surg. 2024 Mar 15;14(3):2255-2266. doi: 10.21037/qims-23-1148. Epub 2024 Mar 7.
9
Radiogenomics Provides Insights into Gliomas Demonstrating Single-Arm 1p or 19q Deletion.放射基因组学为显示单臂 1p 或 19q 缺失的神经胶质瘤提供了新的见解。
AJNR Am J Neuroradiol. 2023 Nov;44(11):1270-1274. doi: 10.3174/ajnr.A8034. Epub 2023 Oct 26.
10
Development of a nomogram based on radiomics and semantic features for predicting chromosome 7 gain/chromosome 10 loss in IDH wild-type histologically low-grade gliomas.基于影像组学和语义特征的列线图在预测异柠檬酸脱氢酶(IDH)野生型组织学低级别胶质瘤中7号染色体获得/10号染色体缺失方面的开发
Front Oncol. 2023 Sep 15;13:1196614. doi: 10.3389/fonc.2023.1196614. eCollection 2023.